查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585716

血库市场：按类型、产品和最终用户划分 - 全球预测 2025-2030

Blood Banking Market by Type (Private, Public), Product (Plasma, Platelets, Red Blood Cells), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血库市值为150.1亿美元，预计到2024年将达到168.9亿美元，复合年增长率为12.99%，预计到2030年将达到353.1亿美元。

血库市场是医疗保健服务的重要组成部分，包括人类血液和血液成分的采集、处理、测试、储存和分配。对血库的需求源于其在透过输血拯救生命、治疗各种医疗状况和紧急情况以及支持手术方面发挥的重要作用。重要的应用包括管理血液疾病、支持癌症治疗和协助创伤治疗。最终使用领域包括医院、诊所、血库、门诊手术中心、实验室等。市场成长受到诸如需要输血的慢性疾病盛行率上升、外科手术数量增加、政府为安全和可及的血液供应采取的倡议以及血液保存和储存技术的进步等因素的影响。自动采血系统、病原体减少技术和改进的血液检测方法等创新提供了巨大的机会。透过强调伙伴关係和合作来加强研发，相关人员可以有效地解决这些市场差距。但也存在监管政策严格、血液感染风险、营运成本高、血液采集和储存方法缺乏标准化等挑战。此外，发展中地区的意识低落也是一个主要障碍。为了利用成长机会，相关人员应优先投资行动采血技术并扩大捐血者招募策略。低温运输物流和血液库存管理预测分析的创新可能会彻底改变该产业。市场本质上是动态的，由持续的需求和创新驱动，并且必须不断适应技术进步和监管变化。透过专注于合成血液替代和人造血液的前沿研究，公司可以满足不断变化的需求并降低供应风险。此外，提高公众对捐血及其挽救生命益处的认识和教育将加强我们的市场基础，并确保稳定的血液供应链，以满足不断增长的医疗保健需求。

主要市场统计
基准年[2023] 150.1亿美元
预测年份 [2024] 168.9亿美元
预测年份 [2030] 353.1亿美元
复合年增长率（%） 12.99%

市场动态：揭示快速发展的血库市场的关键市场洞察

供需的动态交互作用正在改变血库市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 血液病患病率高，案例数量不断增加
    • 输血感染疾病和手术增加导致血液传染疾病负担增加
    • 政府和非政府倡议，例如举办捐血营；
    • 爱滋病毒和B型肝炎等输血感染疾病的盛行率很高
  • 市场限制因素
    • 维护和血液处理设备高成本
  • 市场机会
    • 对先进设备的需求增加
    • 积极改变赎回场景
    • 提高捐血和安全输血意识
  • 市场挑战
    • 严格的规章制度场景

波特五力：驾驭血库市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血库市场的外部影响

外部宏观环境因素对血站市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解血库市场的竞争格局

血库市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵血库市场供应商绩效评估

FPNV 定位矩阵是评估血库市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划血库市场的成功之路

血库市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血液病患病率高，事故发生率增加
      • 血液传染疾病的负担正在增加，同时与输血相关的感染疾病和手术也在增加。
      • 政府和非政府倡议，例如举办捐血营
      • 爱滋病毒和B型肝炎等输血传染性行为感染的盛行率很高
    • 抑制因素
      • 维护和血液处理设备成本高昂
    • 机会
      • 对先进设备的需求增加
      • 积极改变赎回场景
      • 提高捐血和安全输血意识
    • 任务
      • 严格的规章制度场景
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 血库市场：依类型

  • 私人的
  • 公共

第七章 血库市场：副产品

  • 电浆
  • 血小板
  • 红血球
  • 白血球
  • 全血

第八章 血库市场：依最终用户分类

  • 门诊手术中心
  • 诊断中心
  • 医院

第九章美洲的血库市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太血库市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的血库市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AMAG Pharmaceuticals, Inc.
  • Americord Registry LLC
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • bioMerieux SA
  • Cardinal Health, Inc
  • China Biologic Products, Inc.
  • Cordlife Group Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Immucor, Inc.
  • Johnson & Johnson
  • Krew Instruments Pvt Ltd
  • Macopharma SA
  • Narang Medical Limited
  • Remi Elektrotechnik Limited
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCord LLC
Product Code: MRR-434CCDA04D00

The Blood Banking Market was valued at USD 15.01 billion in 2023, expected to reach USD 16.89 billion in 2024, and is projected to grow at a CAGR of 12.99%, to USD 35.31 billion by 2030.

The blood banking market, an essential component of healthcare services, encompasses the collection, processing, testing, storage, and distribution of human blood and blood components. The necessity of blood banking arises from its critical role in saving lives through transfusions, treating various medical conditions, emergencies, and supporting surgeries. Vital applications include managing blood disorders, supporting cancer treatments, and aiding trauma care. The end-use sectors encompass hospitals, clinics, blood banks, ambulatory surgical centers, and research laboratories. Market growth is influenced by factors such as the rising prevalence of chronic diseases requiring blood transfusions, increased surgical procedures, government initiatives for safe and accessible blood supply, and advancements in blood storage and preservation techniques. Technological innovations, like automated blood collection systems, pathogen reduction technologies, and improved blood testing methods, provide significant opportunities. Emphasizing partnerships and collaborations for enhanced R&D will enable stakeholders to address these market gaps effectively. However, challenges include stringent regulatory policies, the risk of bloodborne infections, high operational costs, and a lack of standardization in blood collection and storage practices. Additionally, limited awareness in developing regions poses a significant hurdle. To capitalize on growth opportunities, stakeholders should prioritize investments in mobile blood collection technologies and expand donor recruitment strategies. Innovations in cold chain logistics and predictive analytics for blood inventory management can revolutionize the industry. The market's nature is dynamic, driven by consistent demand and innovations, requiring constant adaptation to technological advancements and regulatory changes. By focusing on cutting-edge research in synthetic blood substitutes and artificial blood, businesses can cater to evolving needs and mitigate supply risks. Additionally, enhancing public awareness and education about blood donation and its life-saving benefits can strengthen market foundations and ensure a stable blood supply chain to meet expanding healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 15.01 billion
Estimated Year [2024] USD 16.89 billion
Forecast Year [2030] USD 35.31 billion
CAGR (%) 12.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Banking Market

The Blood Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of hematologic diseases and rising incidences of accidental cases
    • Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
    • Government and non-government initiatives such as conduction of blood donation camps
    • High prevalence of transfusion transmissible infections such as HIV and hepatitis B
  • Market Restraints
    • High cost of maintenance and blood processing equipment
  • Market Opportunities
    • Increasing demand for advanced instruments
    • Positively changing reimbursement scenarios
    • Growing awareness about blood donation and safe blood transfusion
  • Market Challenges
    • Stringent rules and regulations scenario

Porter's Five Forces: A Strategic Tool for Navigating the Blood Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Banking Market

A detailed market share analysis in the Blood Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Banking Market

A strategic analysis of the Blood Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Banking Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMAG Pharmaceuticals, Inc., Americord Registry LLC, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc, bioMerieux SA, Cardinal Health, Inc, China Biologic Products, Inc., Cordlife Group Limited, F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Immucor, Inc., Johnson & Johnson, Krew Instruments Pvt Ltd, Macopharma SA, Narang Medical Limited, Remi Elektrotechnik Limited, Terumo BCT, Inc., Thermo Fisher Scientific Inc., and ViaCord LLC.

Market Segmentation & Coverage

This research report categorizes the Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Private and Public.
  • Based on Product, market is studied across Plasma, Platelets, Red Blood Cells, White Blood Cells, and Whole Blood.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of hematologic diseases and rising incidences of accidental cases
      • 5.1.1.2. Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
      • 5.1.1.3. Government and non-government initiatives such as conduction of blood donation camps
      • 5.1.1.4. High prevalence of transfusion transmissible infections such as HIV and hepatitis B
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of maintenance and blood processing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for advanced instruments
      • 5.1.3.2. Positively changing reimbursement scenarios
      • 5.1.3.3. Growing awareness about blood donation and safe blood transfusion
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent rules and regulations scenario
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Banking Market, by Type

  • 6.1. Introduction
  • 6.2. Private
  • 6.3. Public

7. Blood Banking Market, by Product

  • 7.1. Introduction
  • 7.2. Plasma
  • 7.3. Platelets
  • 7.4. Red Blood Cells
  • 7.5. White Blood Cells
  • 7.6. Whole Blood

8. Blood Banking Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals

9. Americas Blood Banking Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Banking Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Banking Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AMAG Pharmaceuticals, Inc.
  • 3. Americord Registry LLC
  • 4. Beckman Coulter, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories Inc
  • 7. bioMerieux SA
  • 8. Cardinal Health, Inc
  • 9. China Biologic Products, Inc.
  • 10. Cordlife Group Limited
  • 11. F. Hoffmann-La Roche Ltd
  • 12. Fresenius Kabi AG
  • 13. Immucor, Inc.
  • 14. Johnson & Johnson
  • 15. Krew Instruments Pvt Ltd
  • 16. Macopharma SA
  • 17. Narang Medical Limited
  • 18. Remi Elektrotechnik Limited
  • 19. Terumo BCT, Inc.
  • 20. Thermo Fisher Scientific Inc.
  • 21. ViaCord LLC

LIST OF FIGURES

  • FIGURE 1. BLOOD BANKING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD BANKING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD BANKING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023